Clinical Practice Guideline of Sui Du Lao (Myelodysplastic Syndrome)

摘要

cqvip:This paper developed a guideline for clinical practice of Sui Du Lao (myelodysplastic syndrome).It covers the traditional Chinese medicine (TCM) disease names,syndrome differentiation,prognostic scores,treatment according to the syndrome differentiation,and efficacy evaluation,and the relationships between dose,efficacy,mechanism,and toxicity of Realgar and emergency plans in patients treated orally with TCM preparation containing Realgar .